InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Auchincloss Thomas G, Director. Officer active across 1 companies, notably Concert Pharmaceuticals, INC.. Aggregated, 4 disclosures have been published. Total volume traded: €27k. The latest transaction was disclosed on 6 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations4 total
16,400 shares
Common Stock
SEC:0001209191-22-036284:0·
€26,6576,000 shares@ €4.4428100.0% of flow
Common Stock
SEC:0001209191-22-034579:0·
Ideal exit: 3 Mar 2023 (T+270)
5,125 shares
Common Stock
SEC:0001209191-21-039741:0·
5,125 shares
Common Stock
SEC:0001209191-21-039741·
4 of 4 declarations
About Auchincloss Thomas G
Thomas G. Auchincloss is a Board Member at Concert Pharmaceuticals, Inc. He contributes to the strategic direction of the company, bringing his expertise in biotechnology and product development. His role is essential in supporting innovation and growth.
